Patritumab Deruxtecan

Approval Year

Substance Class	Protein Created by `admin` on `Sat Dec 16 14:22:07 GMT 2023` Edited by `admin` on `Sat Dec 16 14:22:07 GMT 2023`
Protein Type	MONOCLONAL ANTIBODY CONJUGATE
Protein Sub Type	IGG1
Sequence Origin	HUMAN
Sequence Type	COMPLETE
Record UNII	3XPI7EG4W8
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

Patritumab Deruxtecan

Official Name

English

ANTI-HER3 ANTIBODY-DRUG CONJUGATE U3 1402

Common Name

English

patritumab deruxtecan [INN]

Common Name

English

U3-1402A

Code

English

PATRITUMAB DERUXTECAN [JAN]

Common Name

English

Immunoglobulin G1, anti-(human epidermal growth factor receptor HER3) (human monoclonal U3-1287 γ1-chain), complex with human monoclonal U3-1287 κ-chain, dimer, octakis(thioether) with N-[6-(3-mercapto-2,5-dioxo-1-pyrrolidinyl)-1-oxohexyl]glycylglycyl-

Common Name

English

U31402

Code

English

Patritumab deruxtecan [WHO-DD]

Common Name

English

U3-1402

Code

English

Immunoglobulin G1-kappa, anti-[Homo sapiens ERBB3 (receptor tyrosine-protein kinase erbB-3, HER3)], Homo sapiens monoclonal antibody, conjugated to deruxtecan, comprising a linker and a camptothecin derivative; gamma1 heavy chain Homo sapiens (1-447) [VH

Common Name

English

PATRITUMAB DERUXTECAN [USAN]

Common Name

English

Code System Code Type Description

INN

11093